SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Biocomposites to launch SYNICEM™ bone cement in UK to ease supply crisis
February 20, 2026
 · 
3 min read
Press Releases
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
February 20, 2026
 · 
17 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
February 20, 2026
 · 
8 min read
Press Releases
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
February 20, 2026
 · 
13 min read
Press Releases
Henriette Mersebach to step down as ALK’s head of R&D
February 20, 2026
 · 
2 min read
Press Releases
Cantargia Publishes Full Year Report 2025
February 20, 2026
 · 
3 min read
Press Releases
IRLAB has Received Scientific Advisory Board Confirmation on Next Steps for Pirepemat
February 20, 2026
 · 
4 min read
Press Releases
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
February 20, 2026
 · 
13 min read
Press Releases
Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT margin
February 20, 2026
 · 
4 min read
Press Releases
Candel Therapeutics Announces Pricing of Public Offering - February 19, 2026
February 20, 2026
 · 
5 min read
Press Releases
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
February 19, 2026
 · 
2 min read
Press Releases
Veracyte to Participate in Upcoming March 2026 Investor Conferences
February 19, 2026
 · 
1 min read
Press Releases
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
 · 
16 min read
Press Releases
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
February 19, 2026
 · 
4 min read
Press Releases
Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights
February 19, 2026
 · 
16 min read
Press Releases
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
February 19, 2026
 · 
19 min read
Press Releases
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
February 19, 2026
 · 
13 min read
Press Releases
Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
February 19, 2026
 · 
19 min read
Press Releases
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
 · 
19 min read
Press Releases
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL
February 19, 2026
 · 
7 min read
Press Releases
Decorated Senior Army Officer Tal Sullivan Joins Battelle
February 19, 2026
 · 
2 min read
Press Releases
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
February 19, 2026
 · 
7 min read
Press Releases
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
February 19, 2026
 · 
1 min read
Press Releases
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer
February 19, 2026
 · 
29 min read
Press Releases
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 12, 2026
 · 
20 min read
Press Releases
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
February 12, 2026
 · 
1 min read
Press Releases
GE HealthCare management to present at upcoming investor conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
Hoth Therapeutics Receives U.S. Notice of Allowance for Novel Exon-Skipping Therapy Targeting Allergic Diseases
February 12, 2026
 · 
5 min read
Press Releases
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
February 12, 2026
 · 
11 min read
Press Releases
Picard Medical/ SynCardia Highlights Successful Bridge-to-Transplant Case at UCSF Health Using the SynCardia Total Artificial Heart
February 12, 2026
 · 
4 min read
Press Releases
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
 · 
6 min read
Press Releases
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 12, 2026
 · 
5 min read
Press Releases
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
February 12, 2026
 · 
11 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
 · 
6 min read
Load More